Ifigeneia Mavranezouli

PhD student

About Ifigeneia

Ifigeneia obtained her Medical Degree (Hons) from University of Athens in 1999; she then worked in Greece as a primary care doctor for 15 months. In 2003 she completed an MSc in Health Services Management from the London School of Hygiene and Tropical Medicine (LSHTM). She currently holds a senior health economist post at the National Collaborating Centre for Mental Health (NCC-MH), where she has been working for 5 years, providing economic input for NICE clinical guidelines. Prior to her post at the NCC-MH, she worked for a year as a health economist at the National Collaborating Centre for Women's and Children's Health (NCC-WCH).

PhD research

Ifigeneia has been a part-time research degree student at HEDS since 2006. The topic of her thesis is the development of a preference-based measure for people with common mental health problems derived from the CORE-OM (Clinical Outcomes in Routine Evaluation Outcome Measure).

Publications

• Mavranezouli I. Health economics of contraception. Best Practice & Research Clinical Obstetrics and Gynaecology 2009;23(2):187-98.
• Mavranezouli I, East JE, Taylor SA. CT colonography and cost-effectiveness. European Radiology 2008;18(11):2485-97.
• Hubacher D, Mavranezouli I, McGinn E. Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. Contraception 2008;78(1):73-8.
• Mavranezouli I, on behalf of the LARC Guideline Development Group. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Human Reproduction 2008;23(6):1338-45.
• Taylor C, Burbeck R, Mavranezouli I, Richens Y. Developing guidelines for the mental health care of mothers and mothers-to-be. RCM Midwives 2006;9(7):262-3.
• Mavranezouli I, Wilkinson C. Long-acting reversible contraceptives: not only effective, but also a cost-effective option for the NHS. Journal of Family Planning and Reproductive Health Care 2006;32(1):3-5.